参考文献/References:
[1]Cho NH,Shaw JE,Karuranga S,et al.IDF Diabetes Atlas:Global estimates of diabetes prevalence for 2017 and projections for 2045[J].Diabetes Res Clin Pract,2018(138):271-281. [2]Collaboration NCDRF.Worldwide trends in diabetes since 1980:a pooled analysis of 751 population-basedstudies with 4.4 million participants[J].Lancet,387(10027):1513-1530. [3]Alonso N,Moliner P,Mauricio D.Pathogenesis,Clinical Features and Treatment of Diabetic Cardiomyopathy[J].Adv Exp Med Biol,2018(1067):197-217. [4]Gilca GE,Stefanescu G,Badulescu O,et al.Diabetic Cardiomyopathy:Current Approach and Potential Diagnostic and Therapeutic Targets[J].J Diabetes Res,2017(2017):1310265. [5]Carpentier AC.Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy[J].Can J Cardiol,2018,34(5):605-614. [6]Mansor LS,Mehta K,Aksentijevic D,et al.Increased oxidative metabolism following hypoxia in the type 2 diabetic heart,despite normal hypoxia signalling and metabolic adaptation[J].J Physiol,2016,594(2):307-320. [7]Nakanishi T,Kato S.Impact of diabetes mellitus on myocardial lipid deposition:an autopsy study[J].Pathol Res Pract,2014,210(12):1018-1025. [8]Dey D,Basu D,Roy SS,et al.Involvement of novel PKC isoforms in FFA induced defects in insulin signaling[J].Molecular and Cellular Endocrinology,2006,246(1-2):60-64. [9]Bodiga VL,Eda SR,Bodiga S.Advanced glycation end products:role in pathology of diabetic cardiomyopathy[J].Heart Fail Rev,2014,19(1):49-63. [10]Deluyker D,Evens L,Bito V.Advanced glycation end products(AGEs)and cardiovascular dysfunction:focus on high molecular weight AGEs[J].Amino Acids,2017,49(9):1535-1541. [11]Li Z,Abdullah CS,Jin ZQ.Inhibition of PKC-theta preserves cardiac function and reduces fibrosis in streptozotocin-induced diabetic cardiomyopathy[J].Br J Pharmacol,2014,171(11):2913-2924. [12]Zakaria EM,El-Bassossy HM,El-Maraghy NN,et al.PARP-1 inhibition alleviates diabetic cardiac complications in experimental animals[J].Eur J Pharmacol,2016(791):444-454. [13]Al-Jiffri OH,Al-Sharif FM,Al-Jiffri EH,et al.Intrinsic disorder in biomarkers of insulin resistance,hypoadiponectinemia,and endothelial dysfunction among the type 2 diabetic patients[J].Intrinsically Disord Proteins,2016,4(1):e1171278. [14]Li S,Hong Y,Jin X,et al.A new Agkistrodon halys venom-purified protein C activator prevents myocardial fibrosis in diabetic rats[J].Croat Med J,2015,56(5):439-446. [15]符显昭,冯雪萍,丘海先,等.降糖舒心方对糖尿病心肌细胞内质网应激Caspase-12凋亡旁路及心功能的影响[J].中华中医药学刊,2019(9):2423-2427. [16]Wagner S,Rokita AG,Anderson ME,et al.Redox regulation of sodium and calcium handling[J].Antioxid Redox Signal,2013,8(9):1063-1077. [17]薛瑞凤,孙冬梅,郭淑香,等.大鼠糖尿病性心肌病的超声心动图研究[J].中华超声影像学杂志,2008,17(10):903-907. [18]Singh RM,Waqar T,Howarth FC,et al.Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart[J].Heart Fail Rev,2018,23(1):37-54. [19]Zhang GX,Obata K,Takeshita D,et al.Evaluation of left ventricular mechanical work and energetics of normal hearts in SERCA2a transgenic rats[J].J Physiol Sci,2012,62(3):221-231. [20]Roger VL,Go AS,Lloyd-Jones DM,et al.Executive summary:heart disease and stroke statistics-2012 update:a report from the American Heart Association[J].Circulation,2012,125(1):188-197. [21]Ward ML,Crossman DJ.Mechanisms underlying the impaired contractility of diabetic cardiomyopathy[J].World J Cardiol,2014,6(7):577-584. [22]Joseph JJ,Echouffo Tcheugui JB,Effoe VS,et al.Renin-Angiotensin-Aldosterone System,Glucose Metabolism and Incident Type 2 Diabetes Mellitus:MESA[J].J Am Heart Assoc,2018,7(17):e009890. [23]Rosin NL,Falkenham A,Sopel MJ,et al.Regulation and role of connective tissue growth factor in AngII-induced myocardial fibrosis[J].Am J Pathol,2013,182(3):714-726. [24]Thomas CM,Yong QC,Seqqat R,et al.Direct renin inhibition prevents cardiac dysfunction in a diabetic mouse model:comparison with an angiotensin receptor antagonist and angiotensin-converting enzyme inhibitor[J].Clin Sci(Lond),2013,124(8):529-541. [25]肖凤英.糖尿病心肌病与早期扩张性心肌病心肌线粒体通透性转运孔开放的对比观察[J].中国中医药咨讯,2011,3(20):14-15. [26]Joshi M,Kotha SR,Malireddy S,et al.Conundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction,reactive oxygen species,and mitochondria[J].Mol Cell Biochem,2014,386(1-2):233-249. [27]Ansari M,Kurian GA.Hydrogen sulfide preconditioning could ameliorate reperfusion associated injury in diabetic cardiomyopathy rat heart through preservation of mitochondria[J].Biochimie,2019(158):208-216. [28]Mejia EM,Hatch GM.Mitochondrial phospholipids:role in mitochondrial function[J].J Bioenerg Biomembr,2016,48(2):99-112. [29]Pepin ME,Wende AR.Epigenetics in the development of diabetic cardiomyopathy[J].Epigenomics,2019,11(5):469-472. [30]Jia G,Whaley-Connell A,Sowers JR.Diabetic cardiomyopathy:a hyperglycaemia-and insulin-resistance-induced heart disease[J].Diabetologia,2018,61(1):21-28. [31]Miki T,Yuda S,Kouzu H,et al.Diabetic cardiomyopathy:pathophysiology and clinical features[J].Heart Fail Rev,2013,18(2):149-166. [32]Adeghate E,Singh J.Structural changes in the myocardium during diabetes-induced cardiomyopathy[J].Heart Fail Rev,2014,19(1):15-23. [33]Parim B,Sathibabu Uddandrao VV,Saravanan G.Diabetic cardiomyopathy:molecular mechanisms, detrimental effects of conventional treatment,and beneficial effects of natural therapy[J].Heart Fail Rev,2019,24(2):279-299. [34]Pappachan JM,Varughese GI,Sriraman R,et al.Diabetic cardiomyopathy:Pathophysiology,diagnostic evaluation and management[J].World J Diabetes,2013,4(5):177-189. [35]Marwick TH,Ritchie R,Shaw JE,et al.Implications of Underlying Mechanisms for the Recognition and Management of Diabetic Cardiomyopathy[J].J Am Coll Cardiol,2018,71(3):339-351. [36]Lehrke M,Marx N.Diabetes Mellitus and Heart Failure[J].Am J Med,2017,130(6S):S40-S50.
相似文献/References:
[1]张西园.糖尿病与结直肠癌患者预后相关研究进展[J].医学信息,2018,31(01):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
ZHANG Xi-yuan.Research Progress in the Relationship between Diabetes and the Prognosis of Colorectal
Cancer[J].Medical Information,2018,31(02):55.[doi:10.3969/j.issn.1006-1959.2018.01.020]
[2]耿金萍.综合护理对甲状腺良性肿瘤并糖尿病患者手术效果的影响分析[J].医学信息,2018,31(01):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
GENG Jin-ping.Analysis of the Effect of Comprehensive Nursing on the Surgical Effect of Thyroid Benign
Tumor and Diabetic Patients[J].Medical Information,2018,31(02):163.[doi:10.3969/j.issn.1006-1959.2018.01.064]
[3]李雯婷,谈世华,余江明,等.踝肱指数检测在住院糖尿病患者中的重复性研究[J].医学信息,2018,31(03):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
LI Wen-ting,TAN Shi-hua,YU Jiang-ming,et al.Study on Reproducibility of Ankle-brachial Index in Inpatients with Diabetes Mellitus[J].Medical Information,2018,31(02):159.[doi:10.3969/j.issn.1006-1959.2018.03.058]
[4]刘 静.冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析[J].医学信息,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
LIU Jing.Analysis of Blood Lipid Test Results in Coronary Atherosclerotic Heart Disease Complicated with Diabetes Mellitus[J].Medical Information,2018,31(02):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
[5]谢勇丽,苏晓清,张雅薇.糖尿病痛性周围神经病变患者情绪调查分析[J].医学信息,2018,31(05):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
XIE Yong-li,SU Xiao-qing,ZHANG Ya-wei.Investigation and Analysis of Mood in Patients with Diabetic Peripheral Neuropathy[J].Medical Information,2018,31(02):14.[doi:10.3969/j.issn.1006-1959.2018.05.005]
[6]张雅薇,朱明慧.首发为动眼神经麻痹的糖尿病合并动眼神经麻痹误诊为痛性眼肌麻痹1例分析[J].医学信息,2018,31(05):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
ZHANG Ya-wei,ZHU Ming-hui.An Analysis of a Case of Diabetes Mellitus with Oculomotor Nerve Palsy Misdiagnosed as Painful Ophthalmoplegia[J].Medical Information,2018,31(02):23.[doi:10.3969/j.issn.1006-1959.2018.05.008]
[7]张宇宁.黄酮类化合物治疗糖尿病及其并发症的研究[J].医学信息,2018,31(05):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
ZHANG Yu-ning.Study on Flavonoids in the Treatment of Diabetes Mellitus and its Complications[J].Medical Information,2018,31(02):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
[8]柳 梅.头孢哌酮钠舒巴坦钠治疗糖尿病并发尿路感染的
临床效果观察[J].医学信息,2018,31(07):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
LIU Mei.Clinical Efficacy of Cefoperazone Sodium and Sulbactam Sodium in Treatment of Diabetes Complicated with Urinary Tract Infection[J].Medical Information,2018,31(02):139.[doi:10.3969/j.issn.1006-1959.2018.07.047]
[9]吕桂英.影响糖尿病患者药物治疗依从性相关因素临床分析[J].医学信息,2018,31(08):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
LV Gui-ying.Clinical Analysis of Factors Related to Compliance with Drug Therapy in Patients with Diabetes Mellitus[J].Medical Information,2018,31(02):109.[doi:10.3969/j.issn.1006-1959.2018.08.036]
[10]刘爱君.糖化血红蛋白测定在糖尿病诊断中的应用价值分析[J].医学信息,2018,31(08):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
LIU Ai-jun.Analysis of the Value of Determination of Glycosylated Hemoglobin in the Diagnosis of Diabetes Mellitus[J].Medical Information,2018,31(02):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]